Literature DB >> 3093130

Lysosomes and pancreatic islet function: intracellular insulin degradation and lysosomal transformations.

L A Borg, A H Schnell.   

Abstract

Previous observations indicate that substantial amounts of insulin are degraded intracellularly in isolated pancreatic islets exposed to low or physiological glucose concentrations. The intracellular degradation of insulin seems to occur by a crinophagic process. The aim of the present investigation was to elucidate the role of glucose both in the intracellular insulin degradation and in the lysosomal changes associated with crinophagy in the pancreatic islets. Isolated islets were maintained for 1 week in tissue culture at glucose concentrations of either 3.3 or 28 mmol/l. At both glucose concentrations experimental conditions producing both low and high rates of insulin secretion were examined. Differences in intracellular insulin degradation between the low and high insulin secretory conditions were estimated by measuring insulin biosynthesis and the total amounts of intracellular and extracellular insulin in the islet cultures. Primary and secondary lysosomes in the islets were strictly defined by morphological criteria and evaluated by ultrastructural morphometry. The intracellular degradation of insulin was significantly enhanced in the low-secretory conditions, irrespective of the glucose concentration. Also at both glucose concentrations, primary lysosomes occurred with higher frequency in islets with a high insulin secretion, whereas secondary lysosomes predominated in islets with a low rate of secretion. Thus, the degradative process is manifested as a transformation of lysosomes from their primary to their secondary form. Furthermore, it is suggested that glucose does not interfere directly with crinophagy but rather affects intracellular degradation of insulin in the pancreatic B cells by changing retention of secretory material.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3093130

Source DB:  PubMed          Journal:  Diabetes Res        ISSN: 0265-5985


  7 in total

1.  Expedited approaches to whole cell electron tomography and organelle mark-up in situ in high-pressure frozen pancreatic islets.

Authors:  Andrew B Noske; Adam J Costin; Garry P Morgan; Brad J Marsh
Journal:  J Struct Biol       Date:  2007-09-29       Impact factor: 2.867

2.  LIM-homeodomain transcription factor Isl-1 mediates kisspeptin's effect on insulin secretion in mice.

Authors:  Juan Chen; Rui Fu; Yan Cui; Jirong Pan; Yushan Li; Xiaoxin Zhang; Sylvia M Evans; Sheng Cui; Jiali Liu
Journal:  Mol Endocrinol       Date:  2014-06-23

3.  Localisation of islet amyloid peptide in lipofuscin bodies and secretory granules of human B-cells and in islets of type-2 diabetic subjects.

Authors:  A Clark; C A Edwards; L R Ostle; R Sutton; J B Rothbard; J F Morris; R C Turner
Journal:  Cell Tissue Res       Date:  1989-07       Impact factor: 5.249

4.  The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation.

Authors:  M Cnop; S J Hughes; M Igoillo-Esteve; M B Hoppa; F Sayyed; L van de Laar; J H Gunter; E J P de Koning; G V Walls; D W G Gray; P R V Johnson; B C Hansen; J F Morris; M Pipeleers-Marichal; I Cnop; A Clark
Journal:  Diabetologia       Date:  2009-10-24       Impact factor: 10.122

5.  The intracellular handling of insulin-related peptides in isolated pancreatic islets. Evidence for differential rates of degradation of insulin and C-peptide.

Authors:  C J Rhodes; P A Halban
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

6.  Thrombospondin-1: an islet endothelial cell signal of importance for β-cell function.

Authors:  Johan Olerud; Dariush Mokhtari; Magnus Johansson; Gustaf Christoffersson; Jack Lawler; Nils Welsh; Per-Ola Carlsson
Journal:  Diabetes       Date:  2011-05-26       Impact factor: 9.461

7.  Differential sorting of lysosomal enzymes out of the regulated secretory pathway in pancreatic beta-cells.

Authors:  R Kuliawat; J Klumperman; T Ludwig; P Arvan
Journal:  J Cell Biol       Date:  1997-05-05       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.